DMD Clinical Trials

31 recruitingLast updated: June 17, 2026

There are 31 actively recruiting dmd clinical trials across 19 countries. Studies span Phase 2, Phase 1, Not Applicable, Early Phase 1, Phase 3. Top locations include London, United Kingdom, Oxford, United Kingdom, Liège, Belgium. Updated daily from ClinicalTrials.gov.


DMD Trials at a Glance

31 actively recruiting trials for dmd are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Phase 2 with 7 trials, with the heaviest enrollment activity in London, Oxford, and Liège. Lead sponsors running dmd studies include Entrada Therapeutics, Inc., Seoul National University Hospital, and Shanghai Jiao Tong University School of Medicine.

Browse dmd trials by phase

Treatments under study

About DMD Clinical Trials

Looking for clinical trials for DMD? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new DMD trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about DMD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting

A Remote Study Using Technology to Assess Outcomes in DMD

Duchenne Muscular Dystrophy (DMD)
University of Oxford60 enrolled1 locationNCT07423026
Recruiting
Phase 2

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

Duchenne Muscular DystrophyDMDNeuromuscular Diseases+2 more
Satellos Bioscience, Inc.51 enrolled21 locationsNCT07287189
Recruiting

Duchenne Electronic Health Record Study

Becker muscular dystrophyDuchenne Muscular Dystrophy (DMD)Dystrophinopathy+1 more
The Duchenne Registry2,500 enrolled10 locationsNCT07609394
Recruiting
Phase 3

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)

Muscular Dystrophy, DuchenneDMDNeuromuscular Diseases (NMD)+10 more
Dyne Therapeutics90 enrolled1 locationNCT07608432
Recruiting
Not Applicable

The Effect of Virtual Reality Applications on Upper Extremity Functions in Patients With Duchenne Muscular Dystrophy

Virtual RealityDuchenne Muscular Dystrophy (DMD)
Istanbul University36 enrolled1 locationNCT07039799
Recruiting
Phase 1Phase 2

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45

Duchenne Muscular Dystrophy (DMD)
Entrada Therapeutics, Inc.24 enrolled15 locationsNCT07038824
Recruiting
Phase 2

Vasodilator and Exercise Study for DMD (VASO-REx)

ExerciseDuchenne Muscular DystrophyDMD+4 more
University of Florida50 enrolled1 locationNCT06290713
Recruiting
Early Phase 1

Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

Duchenne Muscular Dystrophy (DMD)
Shanghai Siponuoyin Biotechnology Co Ltd9 enrolled1 locationNCT07188012
Recruiting
Phase 1Phase 2

PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD
Precision BioSciences, Inc.18 enrolled1 locationNCT07429240
Recruiting

The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD)
University of Rochester105 enrolled1 locationNCT07092540
Recruiting

Invasive Home Ventilation in Denmark

Spinal Cord Injuries (SCI)Neuromuscular Diseases (NMD)MSA - Multiple System Atrophy+5 more
Rigshospitalet, Denmark450 enrolled1 locationNCT07467187
Recruiting
Not Applicable

Urinary Titin Biomarker in DMD

Duchenne Muscular Dystrophy (DMD)Becker's Muscular Dystrophy (BMD)
Children's Hospital of Philadelphia50 enrolled1 locationNCT07332013
Recruiting

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Duchenne Muscular Dystrophy (DMD)Spinal Muscular Atrophy Type 3
Columbia University106 enrolled3 locationsNCT06839469
Recruiting

DMD Gene Variants and Cardiac Dysfunction in Young Males With Dystrophinopathies

Becker muscular dystrophyCardiomyopathyDuchenne Muscular Dystrophy (DMD)
Aristotle University Of Thessaloniki65 enrolled1 locationNCT07515235
Recruiting
Phase 1Phase 2

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44

Duchenne Muscular Dystrophy (DMD)
Entrada Therapeutics, Inc.24 enrolled14 locationsNCT07037862
Recruiting
Phase 2

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular DystrophyDMDExon 44
NS Pharma, Inc.20 enrolled25 locationsNCT05996003
Recruiting
Phase 1

A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

Duchenne Muscular Dystrophy (DMD)
Grünenthal GmbH24 enrolled1 locationNCT07347548
Recruiting

Swiss Registry for Neuromuscular Disorders

DMDSMABMD+2 more
University of Bern2,000 enrolled19 locationsNCT05102916
Recruiting
Not Applicable

Active NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening

Duchenne Muscular Dystrophy (DMD)Spinal Muscular Atrophy (SMA)
Centre Hospitalier Universitaire de Liege100 enrolled1 locationNCT07286565
Recruiting
Phase 1Phase 2

A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.

DMD
Belief BioMed (Beijing) Co., Ltd9 enrolled1 locationNCT07058662